Jefferies Maintains a 'Buy' on ABIOMED (ABMD); Two Milestones with One Bird

September 5, 2012 7:28 AM EDT Send to a Friend
Jefferies maintains a 'Buy' on ABIOMED (NASDAQ: ABMD) price target of $28.00.

Analyst, Raj Denhoy, said, "ABMD has announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login